查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1247460

2023-2030 年全球視網膜電圖市場

Global Electroretinography Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球視網膜電圖市場預計將實現利潤豐厚的增長，到 2022 年將達到 4842 萬美元，到 2030 年將達到 9352 萬美元。 在預測期內（2023 年至 2030 年），該市場的複合年增長率為 7.2%。

稱為視網膜電圖 (ERG) 的診斷程序檢查視網膜對光刺激的電反應。 除了來自視網膜膠質細胞的輸入外，直接來自視網膜神經元的電流是 ERG 的來源。 ERG具有重要意義，因為它是一種在生理環境下監測視網膜功能的可靠、非侵入性方法。 ERG 通常使用角膜接觸鏡電極或接觸角膜的細纖維電極成像。 這些電極允許眼表記錄從視網膜發出的電活動。

市場動態

視網膜疾病患病率上升

隨著視網膜疾病的增加，市場有望擴大。 例如，預計視網膜疾病患病率的增加將在預測期內推動市場擴張。 例如，根據國家眼科研究所的數據，有 770 萬人患有糖尿病性視網膜病變。 到 2030 年，這一數字預計將增加到 1130 萬。 大約 45% 的糖尿病患者有一定程度的糖尿病視網膜病變。 糖尿病性黃斑水腫是最典型的糖尿病視網膜病變（DME）。 根據 JAMA Ophthalmology，745,000 名美國人患有 DME。

例如，根據 2020 年 NCBI 的數據，40 歲以上人群的視網膜問題患病率在 5.35% 到 21.02% 之間。 雖然直到疾病晚期才出現症狀，但視網膜疾病是富裕國家不可逆轉失明的最常見原因。

高處理成本阻礙市場增長

市場受到阻礙，因為富裕的患者通常無法獲得診斷測試。 我們使用醫院數據、國家勞動力統計數據和政府報銷來創建成本預測。

COVID-19 影響分析

疫情過後，全球視網膜電圖市場有望大幅擴張。 隨著封鎖、旅行限制和企業倒閉，COVID-19 影響了各國的經濟和行業。 COVID-19 問題已使多個國家的公共衛生系統負擔過重，並凸顯了對醫療基礎設施進行長期投資的迫切需求。 隨著 COVID-19 流行病的蔓延，醫療保健行業的發展預計將放緩。 由於全球對體外診斷和研發活動的需求不斷增加，生命科學領域正在蓬勃發展。

但是，由於手術減少和設備採購延遲，醫療技術和成像市場的收入正在下降。 還預計在大流行之後，虛擬醫生對專業人士的訪問將取代親自訪問。 隨著遠程醫療改變醫療保健的提供方式，數字醫療將在未來幾年蓬勃發展。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 片段類型
  • 片段類型
  • 按應用程序摘錄
  • 區域摘要

第 4 章動力學

  • 影響因子
    • 司機
      • 視網膜疾病患病率上升
      • 主要製造商推出新型號和技術進步
    • 約束因素
      • 高昂的處理成本阻礙了市場增長
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按類型

  • 全場閃光 ERG (ffERG)
  • 模式 ERG (PERG)
  • 多焦點 ERG (mfERG)

第 8 章按產品

  • 固定式ERG機
  • 便攜式 ERG 設備

第 9 章按應用

  • 臨床應用
  • 臨床應用

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場分析/份額分析
  • 併購分析

第12章公司簡介

  • Electro-Diagnostic Imaging, Inc.
    • 公司簡介
    • 按類型和說明分類的組合
    • 財務摘要
    • 主要發展
  • Roland Consult Stasche & Finger GmbH
  • Diagnosys LLC
  • Konan Medical USA, Inc.
  • CSO Italia
  • LKC Technologies, Inc
  • Welch Allyn
  • Diopsys, Inc.
  • Metrovision
  • Costruzione Strumenti Oftalmici

第13章 附錄

簡介目錄
Product Code: HCIT1521

Market Overview

The global Electroretinography market reached US$ 48.42 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 93.52 million by 2030. The market is growing at a CAGR of 7.2% during the forecast period (2023-2030).

A diagnostic procedure called an electroretinogram (ERG) examines the retina's electrical reaction to a light stimulus. In addition to input from retinal glia, currents produced directly by retinal neurons are the source of the ERG. It's significant because the ERG is a reliable, non-invasive way to monitor retinal function in physiological settings. ERGs are frequently captured with the aid of a corneal contact lens electrode or a thin fiber electrode that is placed in contact with the cornea. These electrodes enable the ocular surface to record the electrical activity produced by the retina.

Market dynamics

Rising prevalence of retinal diseases

Market growth is predicted to increase with an increase in retinal disorders. For instance, over the forecast period, it is anticipated that the increased prevalence of retinal illnesses will fuel market expansion. For instance, 7.7 million people have diabetic retinopathy, according to the National Eye Institute. This figure is projected to rise to 11.3 million by the year 2030. Around 45% of patients with diabetes get diabetic retinopathy to some extent. Diabetic macular edema is the most typical type of diabetic retinopathy (DME). According to JAMA Ophthalmology, 745,000 Americans have DME.

For instance, according to the NCBI in 2020, the prevalence of retinal problems in persons over 40 ranges from 5.35% to 21.02%. While they are asymptomatic until the later stages of the disease, retinal diseases are the most frequent cause of irreversible blindness in affluent countries.

The high cost of treatment will hamper the growth of the market.

The market is hampered because wealthy patients typically cannot get diagnostic tests. Using hospital data, national labor statistics, and government insurance reimbursement, the cost projections were created.

COVID-19 Impact Analysis

Following the pandemic, the worldwide electroretinography market is anticipated to expand significantly. Due to lockdowns, travel restrictions, and business closures, the COVID-19 has had an impact on the economies and industries of many different nations. The COVID-19 problem has put an excessive strain on public health systems in several nations and emphasized the critical need for long-term investments in healthcare infrastructure. The healthcare sector's development is anticipated to slow as the COVID-19 pandemic spreads. The life sciences sector is thriving as a result of expanding global demand for in vitro diagnostic goods and R&D activity.

Yet, the medical technologies and imaging market is experiencing a decline in revenues as a result of fewer operations being performed and postponed or delayed equipment procurement. Also, after the pandemic, it is anticipated that virtual consultations between medical professionals will replace in-person consultations. Digital health will flourish in the years to come as telehealth transforms the way that healthcare is delivered.

Segment Analysis

The global Electroretinographymarket is segmented based type, Type, application and region.

The full-field flash ERG (ffERG) segment is anticipated to register the highest growth rate.

All through the projected period, the full-field flash ERG (ffERG) segment is anticipated to register the highest CAGR. The retina's mass response, known as the Full-field flash ERG (ffERG), is the aggregate of responses from different retinal sources. This is helpful for conditions like rod/cone dystrophies, cancer-associated retinopathy, and toxic retinopathies that cause widespread retinal impairment. It's important to note that the ffERG is ineffective for identifying tiny retinal lesions. The strength of the stimulus flash and the degree of adaptation both affect the components of the ffERG waveform and their underlying origins.

ffERG is an effective instrument to identify retinal pathology, track the level of retinal malfunction, and evaluate the effects of medical treatment on the retina in a clinical context. The examination of conditions including diabetic retinopathy, glaucoma, and retinitis pigmentosa, as well as the detection of toxic medication effects on the retina before serious, vision-threatening damage is done, have all been made possible by the use of ffERGs. The segment dominates the market because of the features.

Geographical Analysis

Rapid advancements in healthcare infrastructure drives the market

The market for electroretinography in North America is anticipated to have significant expansion over the ensuing years due to the region's high prevalence of retinal illnesses, expanding healthcare industry, and supportive governmental regulations.

For instance, around three million Americans, or 1% of the population, have glaucoma, according to the CDC 2021. This number is projected to rise as the American population ages; glaucoma is the third most common cause of blindness globally, contributing to up to 14% of the total number of blind people.

Optometrists and their colleagues will surely work to enhance and expand the range of services provided to glaucoma patients as the prevalence of the disease rises. We polled 667 optometrists in May 2021 to find out more about their methods for diagnosing, treating, and managing glaucoma. According to the respondents, 18% of their patients had glaucoma diagnoses, a disparity that only serves to highlight how crucial eyecare has become for the aging US population.

Competitive Landscape

The major global players Electro-Diagnostic Imaging, Inc., Roland Consult Stasche & Finger GmbH, Diagnosys LLC, Konan Medical USA, Inc., CSO Italia, LKC Technologies, Inc, Welch Allyn, Diopsys, Inc., Metrovision, Costruzione Strumenti Oftalmici.

Why Purchase the Report?

  • To visualize the global Electroretinography market segmentation based on Type, Product, Application and region,as well as understandkey commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Electroretinography market-level with all segments.
  • PDF report consists of a comprehensiveanalysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key Types of all the major players.

The global Electroretinography market report would provide approximately 61 tables,62figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising the prevalence of retinal diseases.
      • 4.1.1.2. New Type launches and technological advancements by the key players.
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of treatment will hamper the growth of the market.
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. PostCOVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Full-field flash ERG (ffERG) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pattern ERG (PERG)
  • 7.4. Multifocal ERG (mfERG)

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Fixed ERG Machines*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable ERG Machines

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Clinical Application*
    • 9.2.1. Introduction
  • 9.3. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.4. Clinical Application

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Electro-Diagnostic Imaging, Inc *
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Roland Consult Stasche & Finger GmbH
  • 12.3. Diagnosys LLC
  • 12.4. Konan Medical USA, Inc.
  • 12.5. CSO Italia
  • 12.6. LKC Technologies, Inc
  • 12.7. Welch Allyn
  • 12.8. Diopsys, Inc.
  • 12.9. Metrovision
  • 12.10. Costruzione Strumenti Oftalmici

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us